1990 | 2017 | 1990–2017* | |||
No. of cases (×1 million) | Prevalence (%)‡ | No. of cases (×1 million) | Prevalence (%) | EAPC (95% CI) | |
Overall | 391.2 | 8.2 | 882.1 | 10.9 | 1.05 (1.04 to 1.07) |
Sex | |||||
Male | 236.4 | 10.0 | 524.0 | 13.2 | 1.00 (0.99 to 1.02) |
Female | 154.8 | 6.4 | 358.1 | 8.7 | 1.12 (1.10 to 1.13) |
Sociodemographic Index | |||||
High | 76.2 | 6.7 | 137.4 | 9.0 | 1.14 (1.06 to 1.21) |
High-middle | 100.2 | 9.4 | 224.5 | 13.1 | 1.21 (1.17 to 1.25) |
Middle | 120.0 | 9.4 | 282.3 | 12.2 | 0.94 (0.92 to 0.96) |
Middle-low | 62.3 | 8.0 | 157.1 | 10.5 | 1.01 (1.00 to 1.02) |
Low | 30.4 | 6.5 | 76.2 | 7.9 | 0.74 (0.70 to 0.79) |
Age (years)† | |||||
15–49 | 241.5 | 8.8 | 489.1 | 12.5 | 1.25 (1.22 to 1.28) |
50–69 | 109.1 | 15.9 | 281.5 | 21.4 | 1.06 (1.04 to 1.08) |
≥70 | 40.7 | 20.0 | 111.4 | 25.7 | 0.93 (0.89 to 0.96) |
GBD region | |||||
Andean Latin America | 2.5 | 8.8 | 7.1 | 12.0 | 1.13 (1.10 to 1.16) |
Australasia | 1.5 | 6.4 | 3.1 | 8.6 | 1.16 (1.04 to 1.28) |
Caribbean | 2.8 | 9.2 | 5.8 | 11.7 | 1.03 (0.98 to 1.07) |
Central Asia | 3.8 | 6.7 | 7.4 | 8.5 | 0.91 (0.81 to 1.01) |
Central Europe | 9.5 | 6.7 | 13.1 | 8.0 | 0.70 (0.67 to 0.73) |
Central Latin America | 12.7 | 10.5 | 36.5 | 14.4 | 1.17 (1.14 to 1.21) |
Central sub-Saharan Africa | 2.3 | 6.5 | 6.2 | 7.5 | 0.58 (0.50 to 0.67) |
East Asia | 111.8 | 9.6 | 242.8 | 12.6 | 0.88 (0.82 to 0.95) |
Eastern Europe | 18.4 | 7.0 | 23.7 | 8.4 | 0.73 (0.64 to 0.82) |
Eastern sub-Saharan Africa | 7.1 | 6.0 | 18.0 | 7.0 | 0.58 (0.55 to 0.60) |
High-income Asia Pacific | 11.4 | 5.7 | 18.7 | 7.0 | 0.78 (0.75 to 0.82) |
High-income North America | 23.1 | 7.2 | 44.0 | 9.6 | 1.17 (1.06 to 1.29) |
North Africa and Middle East | 35.0 | 14.3 | 108.0 | 19.3 | 1.12 (1.10 to 1.15) |
Oceania | 0.6 | 12.8 | 1.6 | 16.3 | 0.90 (0.87 to 0.92) |
South Asia | 53.6 | 6.4 | 131.2 | 8.0 | 0.81 (0.78 to 0.83) |
Southeast Asia | 39.5 | 10.9 | 98.5 | 14.5 | 1.12 (1.08 to 1.15) |
Southern Latin America | 3.1 | 6.5 | 6.3 | 8.6 | 1.05 (1.01 to 1.08) |
Southern sub-Saharan Africa | 3.7 | 9.3 | 8.1 | 11.4 | 0.73 (0.69 to 0.77) |
Tropical Latin America | 9.8 | 8.0 | 26.7 | 11.1 | 1.17 (1.15 to 1.19) |
Western Europe | 30.9 | 6.5 | 52.1 | 8.9 | 1.17 (1.05 to 1.29) |
Western sub-Saharan Africa | 8.4 | 6.5 | 23.2 | 8.0 | 0.69 (0.63 to 0.75) |
*The prevalence has been standardised by age.
†Crude prevalence rate for each age group.
‡P values of all EAPCs were <0.001.
EAPC, estimated annual percentage change; GBD, Global Burden of Disease; NAFLD, non-alcoholic fatty liver disease.